|
miRNA
|
ER positive breast cancer
|
ER negative breast cancer
|
logFC
|
p*
|
|---|
|
Mean
|
SD
|
Mean
|
SD
|
|---|
|
miR-342-3p
|
7.60
|
0.79
|
6.72
|
0.51
|
0.881
|
2.29E−4
|
|
let-7b-5p
|
10.36
|
0.79
|
9.48
|
0.64
|
0.878
|
2.76E−4
|
|
miR-125a-3p
|
9.01
|
0.46
|
8.50
|
0.42
|
0.514
|
2.76E−4
|
|
miR-146a-5p
|
6.04
|
0.40
|
6.60
|
0.74
|
− 0.561
|
5.16E−4
|
|
miR-3182
|
9.74
|
0.82
|
10.64
|
0.92
|
− 0.900
|
7.20E−4
|
|
miR-146b-5p
|
6.59
|
0.36
|
7.03
|
0.56
|
− 0.442
|
9.16E−4
|
|
miR-222-3p
|
6.97
|
0.40
|
7.43
|
0.63
|
− 0.464
|
0.0021
|
|
miR-142-3p
|
6.85
|
0.48
|
7.39
|
0.76
|
− 0.540
|
0.0030
|
|
let-7c
|
8.36
|
0.67
|
7.79
|
0.41
|
0.564
|
0.0045
|
|
miR-342-5p
|
6.67
|
0.42
|
6.30
|
0.33
|
0.365
|
0.0048
|
|
miR-155-5p
|
7.28
|
0.24
|
7.53
|
0.40
|
− 0.251
|
0.011
|
|
miR-let-7a-5p
|
9.28
|
0.79
|
8.68
|
0.49
|
0.595
|
0.017
|
|
miR-920
|
7.05
|
0.22
|
7.22
|
0.19
|
− 0.171
|
0.018
|
|
miR-214-3p
|
8.33
|
0.42
|
8.00
|
0.41
|
0.337
|
0.018
|
|
miR-223-5p
|
6.35
|
0.38
|
6.68
|
0.50
|
− 0.332
|
0.020
|
|
miR-574-3p
|
7.50
|
0.19
|
7.34
|
0.21
|
0.154
|
0.027
|
|
miR-3135a
|
6.42
|
0.14
|
6.54
|
0.22
|
− 0.126
|
0.033
|
|
miR-20a-5p
|
6.58
|
0.42
|
7.00
|
0.86
|
− 0.420
|
0.040
|
|
miR-221-3p
|
6.64
|
0.26
|
6.87
|
0.41
|
− 0.223
|
0.042
|
|
miR-665
|
9.15
|
0.52
|
9.56
|
0.68
|
− 0.410
|
0.042
|
|
miR-4758-3p
|
6.60
|
0.29
|
6.81
|
0.28
|
− 0.205
|
0.044
|
|
miR-4419b
|
11.28
|
0.28
|
11.47
|
0.24
|
− 0.195
|
0.044
|
|
miR-4436b-3p
|
6.85
|
0.32
|
7.07
|
0.26
|
− 0.219
|
0.044
|
- Expression levels are given as the mean with standard deviation (SD) of log2 transformed intensity values (Hy3) by microarray analyses
- * False discovery rate (FDR) adjusted p-value. E indicates exponential number
